About The Transplant Program

In 1971, a small group of physicians decided that Hartford Hospital should offer organ transplantation to the residents of southern New England. Our first kidney transplant was performed on March 25, 1971. Robert Schweizer, MD and Stanley Bartus, MD were both involved in this historic surgery. As the technology and science of transplantation advanced, liver and heart transplantation programs were initiated in 1984. Today, the Transplant Program is under the direction of Dr. David Hull.

 

Our goal at the Hartford Hospital Transplant Program is to provide the highest quality patient-centered care in a community setting. Our multidisciplinary approach to patient care utilizes the enormous talents and resources of a broad team. Our physicians, coordinators and nursing staff are all highly trained individuals with many years of experience in the transplant field providing pre-operative, peri-operative and post-transplant care.

 

The Transplant Program is certified by the United Network for Organ Sharing (UNOS). In addition, Hartford Hospital is a JCAHO accredited institution and associated with the UCONN Medical School Training Program.

 

The Transplant Program also has an onsite Histocompatibility Laboratory. Our Organ Procurement Organization (LifeChoice Donor Services) is located in Windsor, CT. Finally, all organ programs (kidney, heart and liver) are Medicare certified for transplantation.

 

New initiatives are constantly underway. Some of these include expanding the living donor pool, cryosurgery and associated technologies for liver cancer, increased public presence for our center, centers of excellence designation with third party payors and our laparoscopic and hand-assisted laparoscopic live kidney donation.

As of Jan. 1, 2008, our transplant program has performed over...

 
On Dec. 5, 1999, the Transplant Program received an Official Statement from the Governor of CT. recognizing the 15th Anniversary of the Heart Transplant Program.
 
The Transplant Program provides access to the latest advances in transplant science and immuno-suppressive medication therapy.

 

The Transplant Program provides neoadjuvant and ablation therapy (cryo and Radio Frequency) for primary liver cancer prior to transplantation.

 

The Transplant Program Team is experienced in reduced size and split liver transplantation.